Evidence map›Paper›PMID 24284076›Full record

ArticleJournal of cell science2014

Integrins promote cytokinesis through the RSK signaling axis.

Shomita S Mathew, Bethsaida Nieves, Sharon Sequeira, Savitha Sambandamoorthy, Kevin Pumiglia, Melinda Larsen, Susan E Laflamme

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. An allergenic plant calmodulin fromFrontiers in immunology · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Connections between the cell cycle, cell adhesion and the cytoskeleton.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  8. Article
  9. Integrin and microtubule crosstalk in the regulation of cellular processes.Cellular and molecular life sciences : CMLS · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Shomita S MathewCenter for Cell Biology and Cancer Research, Albany Medical College, Albany, NY 12208, USA.
Bethsaida Nieves
Sharon Sequeira
Savitha Sambandamoorthy
Kevin Pumiglia
Melinda Larsen
Susan E Laflamme
Albany Medical Center Hospital · USAlbany State University · USUniversity at Albany, State University of New York · US

Funding

INTEGRIN INTRACELLULAR FUNCTIONR01GM051540 · NIGMS · ALBANY MEDICAL COLLEGE · PI LAFLAMME, SUSAN · 1994 to 2018
$4.9M
Engineering Functional Salivary Glands Using Micropatterned ScaffoldsR01DE022467 · NIDCR · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI CASTRACANE, JAMES, LARSEN, MELINDA · 2012 to 2016
$2.4M
VEGF SIGNAL TRANSDUCTION AND TUMOR ANGIOGENESISR01CA081419 · NCI · ALBANY MEDICAL COLLEGE · PI PUMIGLIA, KEVIN M · 1999 to 2008
$2.0M
Engineering Functioning Salivary Glands Using Micropatterned ScaffoldsR56DE022467 · NIDCR · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI CASTRACANE, JAMES, LARSEN, MELINDA · 2017 to 2017
$653k
Rac GTPase signaling during embryonic salivary gland branching morphogenesisF32DE020980 · NIDCR · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI SEQUEIRA, SHARON · 2011 to 2012
$102k
NCI NIH HHS R01 CA081419NIDCR NIH HHS DE02184101NIDCR NIH HHS DE022467NIDCR NIH HHS F32 DE020980NIDCR NIH HHS F32DE20980NIDCR NIH HHS R01 DE022467NIDCR NIH HHS R56 DE022467NIGMS NIH HHS GM51540NIGMS NIH HHS R01 GM051540
6 · The paper itself

Abstract

Cytokinesis is the final stage in cell division. Although integrins can regulate cytokinesis, the mechanisms involved are not fully understood. In this study, we demonstrate that integrin-regulated ERK (extracellular signal-related kinase) and RSK (p90 ribosomal S6 kinase) signaling promotes successful cytokinesis. Inhibiting the activation of ERK and RSK in CHO cells by a mutation in the integrin β1 cytoplasmic tail or with pharmacological inhibitors results in the accumulation of cells with midbodies and the formation of binucleated cells. Activation of ERK and RSK signaling by the expression of constitutively active RAF1 suppresses the mutant phenotype in a RSK-dependent manner. Constitutively active RSK2 also restores cytokinesis inhibited by the mutant integrin. Importantly, the regulatory role of the RSK pathway is not specific to CHO cells. MCF-10A human mammary epithelial cells and HPNE human pancreatic ductal epithelial cells exhibit a similar dependence on RSK for successful cytokinesis. In addition, depriving mitotic MCF10A cells of integrin-mediated adhesion by incubating them in suspension suppressed ERK and RSK activation and resulted in a failure of cytokinesis. Furthermore, inhibition of RSK or integrins within the 3D context of a developing salivary gland organ explant also leads to an accumulation of epithelial cells with midbodies, suggesting a similar defect in cytokinesis. Interestingly, neither ERK nor RSK regulates cytokinesis in human fibroblasts, suggesting cell-type specificity. Taken together, our results identify the integrin-RSK signaling axis as an important regulator of cytokinesis in epithelial cells. We propose that the proper interaction of cells with their microenvironment through integrins contributes to the maintenance of genomic stability by promoting the successful completion of cytokinesis.

Indexed as

AnimalsCHO CellsCricetinaeCricetulusCytokinesisEpithelial CellsHumansIntegrin beta1IntegrinsMAP Kinase Signaling SystemPhosphorylationRibosomal Protein S6 Kinases, 90-kDaSignal TransductionIntegrin beta1IntegrinsRibosomal Protein S6 Kinases, 90-kDaCytokinesisERK, RSKIntegrins

Identifiers

PMID24284076
PMCPMC4007764
OpenAlexW2015870142

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.